Harrow, Inc. Files Definitive Additional Materials
Ticker: HROW · Form: DEFA14A · Filed: Apr 26, 2024 · CIK: 1360214
| Field | Detail |
|---|---|
| Company | Harrow, INC. (HROW) |
| Form Type | DEFA14A |
| Filed Date | Apr 26, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, disclosure, company-update
TL;DR
Harrow Inc. dropped more shareholder docs, check the latest filings.
AI Summary
Harrow, Inc. filed a Definitive Additional Materials (DEFA14A) on April 26, 2024. This filing relates to materials provided to shareholders, likely concerning an upcoming meeting or vote. The company, previously known as Harrow Health, Inc., is incorporated in Delaware and based in Nashville, TN.
Why It Matters
This filing indicates that Harrow, Inc. is providing supplementary information to its shareholders, which could be crucial for understanding upcoming corporate decisions or events.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of additional materials to shareholders and does not inherently present new financial or operational risks.
Key Players & Entities
- HARROW, INC. (company) — Registrant
- Harrow Health, Inc. (company) — Former Company Name
- Imprimis Pharmaceuticals, Inc. (company) — Former Company Name
- TRANSDEL PHARMACEUTICALS INC (company) — Former Company Name
- 20240426 (date) — Filing Date
FAQ
What type of SEC filing is this for Harrow, Inc.?
This is a DEFA14A filing, specifically marked as Definitive Additional Materials.
When was this filing made?
The filing was made on April 26, 2024.
What is Harrow, Inc.'s primary business classification according to the filing?
Harrow, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
What are some of Harrow, Inc.'s previous company names?
Harrow, Inc. was formerly known as Harrow Health, Inc., Imprimis Pharmaceuticals, Inc., and TRANSDEL PHARMACEUTICALS INC.
Where is Harrow, Inc. incorporated and what is its business address?
Harrow, Inc. is incorporated in Delaware and its business address is 102 Woodmont Blvd, Suite 610, Nashville, TN 37215.
Filing Stats: 116 words · 1 min read · ~1 pages · Grade level 13.8 · Accepted 2024-04-26 16:02:19
Filing Documents
- formdefa14a.htm (DEFA14A) — 14KB
- formdefa14a_001.jpg (GRAPHIC) — 1118KB
- formdefa14a_002.jpg (GRAPHIC) — 714KB
- 0001493152-24-016426.txt ( ) — 2535KB
From the Filing
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 HARROW, INC. (Name of Registrant as Specified In Its Charter) (Name of person(s) filing proxy statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee paid previously with preliminary materials. Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.